Filed before 2025Filed 21 May 2020
Good Therapeutics, Inc. has sold $22.3M so far
Good Therapeutics, Inc., a biotech company based in Seattle, WA, has sold $22.3M so far in its equity round, according to a filing dated 21 May 2020.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 21 May 2020
- First filed
- 21 November 2018
- Round
- Equity round (amended filing)
- Amount sold
- $22.3M
- Offering size
- $22.3M
- Investors so far
- 6
- Based in
- Seattle, WA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
3 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 76% of the 1,744 tracked raises with an amount filed in 2020, and than 53% of the 152 in biotech.
Good Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 22 Dec 2021 | New filing | $8.81M | Another raise |
| 21 May 2020 | Amended filing | $22.3M | This raise |
| 8 Feb 2019 | Amended filing | $11.2M | This raise |
| 21 Nov 2018 | New filing | $6.04M | This raise |
More with RiverVest on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.